Caterinea Fimiani

Title: Caterinea Fimiani: Innovator in Receptor Agonist Identification

Introduction

Caterinea Fimiani is a notable inventor based in Rome, Italy. He has made significant contributions to the field of receptor biology, particularly in the identification of estrogen surface receptor agonists. His work has implications for various medical conditions, including cancers and cardiovascular diseases.

Latest Patents

Caterinea Fimiani holds a patent titled "Methods for identifying estrogen surface receptor agonists." This invention relates to mu3 opiate receptors, cannabinoid receptors, and estrogen surface receptors (ESRs). The patent provides methods and materials for identifying mu3 opiate receptor agonists and antagonists, cannabinoid receptor agonists and antagonists, and ESR agonists and antagonists. Additionally, it includes an isolated nucleic acid molecule that encodes a mu3 opioid receptor and an isolated mu3 opioid receptor polypeptide. The invention also outlines methods and materials for treating cancers, inflammatory conditions, sepsis conditions, viral infections, and cardiovascular diseases. Caterinea has 1 patent to his name.

Career Highlights

Throughout his career, Caterinea has focused on advancing the understanding of receptor mechanisms and their therapeutic potential. His innovative approaches have positioned him as a key figure in receptor research.

Collaborations

Caterinea Fimiani has collaborated with George B Stefano, enhancing the scope and impact of his research endeavors.

Conclusion

Caterinea Fimiani's work in identifying receptor agonists represents a significant advancement in medical research, with the potential to improve treatment options for various diseases. His contributions continue to influence the field of receptor biology.